Conflict at a World Renowned Scientific Institution Highlights The Struggle For Objectivity in Medicine
geralt / Pixabay

Conflict at a World Renowned Scientific Institution Highlights The Struggle For Objectivity in Medicine

According to a story from blogs.bmj.com, the situation has been tense recently in the halls of the Cochrane Collaboration. Cochrane is a non-profit organization that involves the work of over…

Continue Reading Conflict at a World Renowned Scientific Institution Highlights The Struggle For Objectivity in Medicine

Experimental Treatment For Small Cell Lung Cancer Receives Orphan Drug Designation

According to a story from pm360online.com, the drug development company Cytori Therapeutics recently announced that its investigational product ATI-1123 has been granted Orphan Drug designation from the US Food and…

Continue Reading Experimental Treatment For Small Cell Lung Cancer Receives Orphan Drug Designation
Cows, Cud-Chewing, and Contentment: Phyllis’s Rumination Syndrome Story
wernerdetjen / Pixabay

Cows, Cud-Chewing, and Contentment: Phyllis’s Rumination Syndrome Story

Three large black and white beasts rest under a shade tree to avoid the sun’s hot rays. They appear to be chewing gum, although they are really chewing their cud.…

Continue Reading Cows, Cud-Chewing, and Contentment: Phyllis’s Rumination Syndrome Story

Genetic Sequencing After Stem Cell Transplant Can Inform Outcomes in Myelodysplatic Syndromes

According to a story from Hematology Times, a recent study found that genetic sequencing after the completion of a hematopoietic stem cell transplant could provide doctors with vital information about…

Continue Reading Genetic Sequencing After Stem Cell Transplant Can Inform Outcomes in Myelodysplatic Syndromes
Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published
allinonemovie / Pixabay

Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published

According to a story from pm360online.com, the biopharmaceutical company Insmed Incorporated recently announced that the data from its Phase 3 clinical trial of amikacin liposome inhalation suspension (ALIS). ALIS was…

Continue Reading Phase 3 Data For Nontuberculous Lung Disease Trial Has Been Published
The American College of Medical Genetics and Genomics Have Addressed High Drug Costs for Patients with Rare Diseases
Pexels / Pixabay

The American College of Medical Genetics and Genomics Have Addressed High Drug Costs for Patients with Rare Diseases

Recent medical developments have led to new drugs designed to treat rare genetic disorders. However, the high cost of many of these drugs limits the number of patients who have…

Continue Reading The American College of Medical Genetics and Genomics Have Addressed High Drug Costs for Patients with Rare Diseases

Charles River Laboratories’ 2nd Annual World Congress

  • Post author:
  • Post category:

The 2nd Annual World Congress Lessons Learned From Rare Disease and Personalized Medicine Approaches This conference will explore strategies for drug discovery, innovative therapeutic approaches, and personalized medicine, with an…

Continue Reading Charles River Laboratories’ 2nd Annual World Congress
Immunotherapy Treatment for Acute Lymphoblastic Leukemia to be Covered on England’s NHS
12019 / Pixabay

Immunotherapy Treatment for Acute Lymphoblastic Leukemia to be Covered on England’s NHS

According to a story from BioPortfolio, the immunotherapy drug Kymriah, a type of CAR-T cell therapy, will be funded by NHS England for the treatment of patients with acute lymphoblastic…

Continue Reading Immunotherapy Treatment for Acute Lymphoblastic Leukemia to be Covered on England’s NHS